Slingshot members are tracking this event:
Phase 3 clinical trial to evaluate 33A in combination with HMAs in previously untreated older AML patients is planned to begin by the third quarter of 2016.
Slingshot Insights Explained
May 25, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords 33a, Hmas, Aml, Acute Myeloid Leukemia, Mds-, Pyrrolobenzodiazepine